GREAT POINT PARTNERS, LLC

GREAT POINT PARTNERS, LLC is a Series C+, buyout and other fund in the US writing $10M–$100M checks into Healthcare, biopharma, medical-devices and health-services.

Stages: Series C+, buyout, other
Sectors: Healthcare, biopharma, medical-devices, health-services
Check size: $10M–$100M
Invests in: US-wide
Round role: Leads rounds
Actively investing: Yes
Founded: 2003
Assets under management: $1.777B

Thesis

Great Point Partners, LLC is a private equity firm founded in 2003 and headquartered in Greenwich, Connecticut. The firm exclusively focuses on the healthcare industry, employing two complementary strategies: lower middle-market growth buyout funds for private healthcare companies and a hedge fund for public life sciences companies. Their investment focus areas include Biopharmaceutical Supply Chain Services and Products, Hospital Outsourcing and Health Care Services, Health Care Information Technology Enabled Services, Medical Devices and Diagnostics, Alternate Site Care, and Medical Device Contract Manufacturing. They often act as the lead investor and are typically the first institutional investor in a company. As of December 31, 2025, the firm had approximately $1.777 billion in Regulatory Assets Under Management (AUM), all managed on a discretionary basis. The firm manages approximately $1.7 billion of invested and committed capital across its public and private equity strategies. Their private equity funds focus on the lower middle market, targeting companies with revenues between $10-100 million and EBITDA between $2-12 million. The target equity investment for these funds ranges from $10-$100 million.

Common questions

Does GREAT POINT PARTNERS, LLC invest at the Series C+ stage?

Yes. GREAT POINT PARTNERS, LLC lists Series C+, buyout and other among the stages it invests in.

What check size does GREAT POINT PARTNERS, LLC write?

GREAT POINT PARTNERS, LLC writes $10M–$100M checks.

Where does GREAT POINT PARTNERS, LLC invest?

GREAT POINT PARTNERS, LLC invests in the US.